Compare ATR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATR | ICLR |
|---|---|---|
| Founded | 1992 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.2B |
| IPO Year | 1995 | 2001 |
| Metric | ATR | ICLR |
|---|---|---|
| Price | $121.37 | $111.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $170.25 | ★ $178.62 |
| AVG Volume (30 Days) | 401.2K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | ★ 6.51 | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $3,777,181,000.00 | N/A |
| Revenue This Year | $5.18 | N/A |
| Revenue Next Year | $4.98 | N/A |
| P/E Ratio | $108.06 | ★ $12.91 |
| Revenue Growth | ★ 5.42 | N/A |
| 52 Week Low | $103.23 | $66.57 |
| 52 Week High | $164.28 | $211.00 |
| Indicator | ATR | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 39.81 | 50.98 |
| Support Level | $118.91 | $102.53 |
| Resistance Level | $125.35 | $116.85 |
| Average True Range (ATR) | 3.81 | 5.50 |
| MACD | -0.64 | 0.28 |
| Stochastic Oscillator | 27.32 | 57.67 |
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.